
By Kurt In Albon, Daniel Davis, PhD, James L. Brooks, Pharmaceutical Technology, Volume 39, Issue 7, pg 46–50, Jul 02, 2015
"Heightened regulatory scrutiny of data integrity highlights the need for comprehensive procedural reviews and strategies for managing mission-critical information."
No comments:
Post a Comment